Reference |
---|
Zhou H, Zeng H, Yuan D, Ren J, Cheng S, Yu H, et al. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma. Cell Commun Signal. 2019;17:168 pubmed publisher
|
Kim J, Park S, Jeong S, Kim B, Na Y, Jo M, et al. Sea Cucumber (Stichopus japonicas) F2 Enhanced TRAIL-Induced Apoptosis via XIAP Ubiquitination and ER Stress in Colorectal Cancer Cells. Nutrients. 2019;11: pubmed publisher
|
Jacobs C, Badiee R, Lin M. StaPLs: versatile genetically encoded modules for engineering drug-inducible proteins. Nat Methods. 2018;15:523-526 pubmed publisher
|
Liu X, Xu J, Li F, Li M, Hu T. Down-regulation of miR-377 contributes to cisplatin resistance by targeting XIAP in osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22:1249-1257 pubmed publisher
|
Ji J, Yu Y, Li Z, Chen M, Deng R, Huang X, et al. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells. Theranostics. 2018;8:1494-1510 pubmed publisher
|
Augeri D, Langenfeld E, Castle M, Gilleran J, Langenfeld J. Inhibition of BMP and of TGF? receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer. 2016;15:27 pubmed publisher
|
Lin F, Ghislat G, Luo S, Renna M, Siddiqi F, Rubinsztein D. XIAP and cIAP1 amplifications induce Beclin 1-dependent autophagy through NFκB activation. Hum Mol Genet. 2015;24:2899-913 pubmed publisher
|
Winkler J, Ori A, Hölzer K, Sticht C, Dauch D, Eiteneuer E, et al. Prosurvival function of the cellular apoptosis susceptibility/importin-?1 transport cycle is repressed by p53 in liver cancer. Hepatology. 2014;60:884-95 pubmed publisher
|
Rajput S, Kumar B, Sarkar S, Das S, Azab B, Santhekadur P, et al. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLoS ONE. 2013;8:e61342 pubmed publisher
|
Ling X, Cao S, Cheng Q, Keefe J, Rustum Y, Li F. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity. PLoS ONE. 2012;7:e45571 pubmed publisher
|